Hyperglycemia (gestational) - Causes, Treatment & When to See a Doctor

What is Hyperglycemia (gestational)?

Gestational hyperglycemia, more commonly referred to as gestational diabetes mellitus (GDM), is a condition in which a woman without previously diagnosed diabetes develops high blood‑glucose levels during pregnancy. The hyperglycemia typically appears in the second or third trimester and resolves after delivery, although it signals an increased risk for developing type 2 diabetes later in life.

During pregnancy the placenta releases hormones that make the mother’s cells slightly resistant to insulin. In most women, the pancreas compensates by producing more insulin. When the pancreas cannot keep up, glucose builds up in the bloodstream, resulting in gestational hyperglycemia.

According to the CDC, GDM affects roughly 6‑9 % of all pregnancies in the United States, but rates vary worldwide based on genetics, diet, and obesity prevalence.

Common Causes

Gestational hyperglycemia is multifactorial. The following conditions and risk factors increase the likelihood of developing it:

• Insulin resistance due to placental hormones – Human placental lactogen, progesterone, estrogen, and cortisol antagonize insulin action.
• Obesity (BMI ≥ 30 kg/m²) – Excess adipose tissue contributes to chronic low‑grade inflammation and insulin resistance.
• Advanced maternal age – Women ≥ 35 years have a higher risk.
• Previous history of gestational diabetes – Recurrence risk is 30‑50 %.
• Family history of type 2 diabetes – First‑degree relatives with diabetes increase risk.
• Polycystic ovary syndrome (PCOS) – Associated with baseline insulin resistance.
• Previous delivery of a macrosomic infant (birth weight > 4 kg) – Indicates prior maternal hyperglycemia.
• Ethnicity – Higher rates in Hispanic, African‑American, Native American, South‑Asian, and Middle‑Eastern populations.
• Pre‑existing impaired glucose tolerance or pre‑diabetes – Even if not classified as diabetes before pregnancy.
• Sedentary lifestyle – Physical inactivity worsens insulin sensitivity.

Associated Symptoms

Many pregnant women with gestational hyperglycemia are asymptomatic, which is why routine screening is crucial. When symptoms do appear, they mimic those of general hyperglycemia:

• Increased thirst (polydipsia) and dry mouth
• Frequent urination (polyuria) – may be mistaken for normal pregnancy‑related bladder pressure
• Fatigue or feeling unusually weak
• Blurred vision
• Recurrent yeast infections or urinary tract infections
• Unexplained weight loss (rare, usually indicates more severe hyperglycemia)

Because these signs overlap with normal pregnancy changes, they are often missed without laboratory testing.

When to See a Doctor

Even though routine prenatal visits include glucose screening, you should contact your obstetrician or midwife promptly if you notice any of the following:

• Persistent excessive thirst or hunger
• Significant increase in urinary frequency beyond normal pregnancy expectations
• Severe fatigue that interferes with daily activities
• Blurry vision that does not improve with rest
• Unusual swelling or rapid weight gain (could signal pre‑eclampsia combined with hyperglycemia)
• Any symptoms of a urinary or vaginal infection that do not resolve with usual treatment

Early evaluation helps prevent complications for both mother and baby.

Diagnosis

Screening for gestational hyperglycemia is usually performed between 24 and 28 weeks of gestation, though high‑risk women may be tested earlier.

Screening Tests

1. Glucose Challenge Test (GCT) – A 50‑g oral glucose load with a single blood draw after 1 hour. A result ≥ 140 mg/dL (7.8 mmol/L) is considered a positive screen and triggers diagnostic testing.
2. One‑step 75‑g Oral Glucose Tolerance Test (OGTT) – Fasting, then 75 g glucose, with plasma glucose measured fasting, at 1 hour, and at 2 hours. Diagnosis of GDM is made if any of the following thresholds are met (per American College of Endocrinology):
   • Fasting ≥ 92 mg/dL (5.1 mmol/L)
   • 1‑hour ≥ 180 mg/dL (10.0 mmol/L)
   • 2‑hour ≥ 153 mg/dL (8.5 mmol/L)

Additional Evaluations

• HbA1c – Not routinely used for diagnosis (physiologic changes in pregnancy affect values) but may help assess pre‑pregnancy glycemic control.
• Ultrasound for fetal growth – Detects macrosomia or excess amniotic fluid, which can arise from maternal hyperglycemia.
• Maternal lipid profile – Dyslipidemia often co‑exists and influences outcomes.

Treatment Options

Management focuses on keeping blood glucose within target ranges (fasting < 95 mg/dL**, 1‑hour post‑meal < 140 mg/dL**)) to reduce fetal over‑nutrition and maternal complications.

Medical Treatments

• Lifestyle modification (first‑line) – Dietary changes and regular moderate exercise are usually sufficient for mild GDM.
• Insulin therapy – Considered the gold standard when glucose goals are not met with diet alone. Short‑acting (e.g., lispro, aspart) before meals and intermediate‑acting (e.g., NPH) at night are common regimens.
• Oral hypoglycemic agents – Metformin and glyburide are FDA‑approved for use in pregnancy when insulin is not feasible. They cross the placenta in small amounts; studies show comparable maternal outcomes but long‑term infant data are still being gathered (NIH).

Home‑Based Management

• Blood glucose monitoring – Self‑testing 4 times daily (fasting and 1‑hour post‑meal) using a calibrated glucometer.
• Medical nutrition therapy – A registered dietitian designs a meal plan delivering 30–40 % of calories from carbohydrates, focusing on complex carbs with a low glycemic index, adequate protein (20‑25 %), and healthy fats (30‑35 %).
• Physical activity – At least 150 minutes of moderate‑intensity aerobic exercise per week (e.g., brisk walking, swimming) unless contraindicated.
• Weight management – For overweight women, a modest weight gain (≈ 7–11 kg total) is recommended by the WHO.
• Stress reduction – Chronic stress elevates cortisol, worsening insulin resistance; techniques include prenatal yoga, deep‑breathing, and adequate sleep.

Prevention Tips

While gestational hyperglycemia cannot be eliminated in every case, the risk can be lowered with the following strategies:

• Achieve a healthy weight before conception (BMI 18.5‑24.9 kg/m²).
• Consume a balanced diet rich in fiber, whole grains, lean protein, and unsaturated fats; limit sugary beverages and processed snacks.
• Engage in regular physical activity – at least 30 minutes most days of the week.
• Screen for pre‑diabetes or impaired glucose tolerance before pregnancy, especially if you have a strong family history.
• Control other modifiable risk factors such as hypertension and dyslipidemia under your physician’s guidance.
• Attend all prenatal appointments; early glucose screening is recommended for women with known risk factors.
• If you have had GDM previously, discuss a pre‑conception plan with your OB‑GYN or endocrinologist.

Emergency Warning Signs

Key Take‑aways

Gestational hyperglycemia is a treatable condition that requires vigilant monitoring, lifestyle adjustments, and sometimes medication to protect maternal and fetal health. Early detection through routine screening, adherence to a personalized nutrition and exercise plan, and prompt communication with your health‑care team can significantly reduce the risk of complications such as macrosomia, pre‑term birth, and future type 2 diabetes.

For detailed guidance tailored to your situation, consult your obstetrician, a certified diabetes educator, or a registered dietitian.

---

References:

1. Mayo Clinic. Gestational diabetes. https://www.mayoclinic.org
2. CDC. Diabetes and Pregnancy. https://www.cdc.gov
3. NIH. Metformin use in gestational diabetes. https://www.ncbi.nlm.nih.gov
4. World Health Organization. Criteria for diagnosis of gestational diabetes mellitus. https://www.who.int
5. Cleveland Clinic. Gestational Diabetes: Overview & Treatment. https://my.clevelandclinic.org